Sun Pharma’s Leqselvi has potential for rapid uptake in US alopecia areata market: GlobalData GlobalData Apr 14, 2025 GlobalData analyst highlights Leqselvi’s high-dose advantage and renewed market entry as key drivers for swift adoption, despite…
Prasinezumab hints PD progression delay as assessed by time-to-event: GlobalData EP News Bureau Apr 7, 2025 While prasinezumab missed its primary endpoint, time-to-event analyses suggest potential in delaying early Parkinson’s disease…
